EUVIMEDScopri EUVIMED
EUVIMED · CrossrefJournal

American Heart Journal

ISSN 0002-8703 · Elsevier BV

Latest articles

  1. Individualized or conventional transfusion strategy during veno-arterial extracorporeal membrane oxygenation support (ICONE study): Rationale and design of a prospective multicentre randomized controlled trial

    Mouhamed Djahoum Moussa, Osama Abou-Arab, Julien Labreuche, Emmanuel Besnier, Pierre-Gregoire Guinot, Fanette Denis, Benoit Dervaux, Yazine Mahjoub, Thibault Duburcq, Saad Nseir, Alain Duhamel, Francis Juthier, Emmanuel Robin, André Vincentelli

    Published: 2027-02DOI: 10.1016/j.ahj.2026.107616

  2. Periprocedural myocardial infarction and clinical outcomes in diffuse vs focal coronary artery disease

    Han Zhang, Daniel Munhoz, Ward Heggermont, Paul Vermeersch, Peter Sinnaeve, Kazumasa Ikeda, Takuya Mizukami, Mitsuaki Matsumura, Jeroen Sonck, Hitoshi Matsuo, Tetsuya Amano, Hirohiko Ando, Masahiro Hada, Brian Ko, Simone Biscaglia, Fernando Rivero, Thomas Engstrøm, Antonio Maria Leone, Lokien X. van Nunen, William F. Fearon, Evald Høj Christiansen, Stephane Fournier, Liyew Desta, Toshiro Shinke, Andy Yong, Julien Adjedj, Javier Escaned, Masafumi Nakayama, Ashkan Eftekhari, Danielle Keulards, Frederik M. Zimmermann, Ethan Korngold, Gianluca Campo, Frédéric Bouisset, Adriaan Wilgenof, Colin Berry, Damien Collison, Thomas W. Johnson, Divaka Perera, Allen Jeremias

    Published: 2027-02DOI: 10.1016/j.ahj.2026.107617

  3. A 0/2-hour algorithm using a novel point-of-care high-sensitivity cardiac troponin I assay for suspected myocardial infarction

    Luca Koechlin, Pedro Lopez-Ayala, Jasper Boeddinghaus, Nina Sigg, Koray Durak, Thomas Nestelberger, Karin Wildi, Ivo Strebel, Paolo Bima, Luca Crisanti, Lourdes Herraiz Recuenco, Alperen Yueksel, Òscar Miró, Francisco Javier Martin-Sanchez, Damian Kawecki, Dagmar I. Keller, Michael Christ, Andreas Buser, Héctor Rodriguez Cetina Biefer, Omer Dzemali, Marianne Nordlund Broughton, Felix Mahfoud, Christian Mueller

    Published: 2027-02DOI: 10.1016/j.ahj.2026.107625

  4. HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics

    Marion M. Mafham, Mohammed G. Zayed, Rory Collins, Marc S. Sabatine, Jane Armitage, Dominic Brittain, Bruno R. da Costa, Fang Chen, Michelle A. Goonasekera, Michael Hill, Jemma C. Hopewell, Martin J. Landray, Michael D. Lay, Anastasia Lesogor, Aldo P. Maggioni, David A. Morrow, Michelle Nunn, Michelle L. O’Donoghue, Kausik K. Ray, Adel Rizkala, Gregory G. Schwartz, Will Stevens, Karl Wallendszus, R. Scott Wright, Rohan Wijesurendra, Elizabeth Wincott, David Preiss, Louise Bowman

    Published: 2027-01DOI: 10.1016/j.ahj.2026.107546

  5. Health status relationship to ischemia and coronary artery disease severity in the ISCHEMIA trial

    Lawrence M. Phillips, Philip G. Jones, Leslee J. Shaw, Daniel B. Mark, Daniel S. Berman, Raymond Y. Kwong, Michael H. Picard, Bernard R. Chaitman, James K. Min, Jelena Celutkiene, Gregg W. Stone, Joao Vitola, Nagaraja Moorthy, Philippe Gabriel Steg, Peter Ong, Whady A. Hueb, Paulo C. Rezende, Judith S. Hochman, David J. Maron, Harmony R. Reynolds, John A. Spertus

    Published: 2027-01DOI: 10.1016/j.ahj.2026.107586

Volumes

2027 · 402026 · 2192025 · 2882024 · 3042023 · 2442022 · 2932021 · 3112020 · 3362019 · 2352018 · 2952017 · 2682016 · 3092015 · 3232014 · 3002013 · 3522012 · 3332011 · 3732010 · 4212009 · 4102008 · 4672007 · 5002006 · 6002005 · 5112004 · 5472003 · 4762002 · 4322001 · 3702000 · 5501999 · 5491998 · 3821997 · 2941996 · 4981995 · 4621994 · 5211993 · 6641992 · 6951991 · 7221990 · 5801989 · 5511988 · 606

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.